Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Atlas-guided discovery of transcription factors for T cell programming.
PMID 41639465 · PMC13017511 · Nature · 2026 · 8 claims · 8 setups
A multi-omics atlas (Taiji pipeline) integrating RNA-seq and ATAC-seq across nine CD8+ T cell states can predict TF activity and identify state-selective versus multi-state TFs
-
Full-text index only
Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory.
PMID 41735532 · PMC12956582 · Nature immunology · 2026 · 8 claims · 8 setups
CD8+ T cells upregulate glycolysis to fuel anabolic needs for proliferation but predominantly use oxidative phosphorylation (OXPHOS) for energy production during the acute phase (days 7-28) after YFV vaccination
-
Full-text index only
Unique phenotypic and T cell receptor characteristics of CD8(+) T cells accumulated in the brains of Alzheimer's disease mice.
PMID 41794902 · PMC13087195 · Scientific reports · 2026 · 8 claims · 5 setups
Brain CD8+ T cells segregate into two major, mutually exclusive Trm populations: a CXCR6-related immunosuppressive cluster (cd8_c0) present in both aged non-Tg and 5xFAD_WT mice, and an AD-associated stem-like cluster (cd8_c1) present only in 5xFAD mice.
-
Full-text index only
Manipulation of Alternative Splicing of IKZF1 Elicits Distinct Gene Regulatory Responses in T Cells.
PMID 41677588 · PMC12896614 · Cells · 2026 · 8 claims · 6 setups
Alternative splicing of IKZF1 in human T cells strongly influences gene expression, chromatin accessibility, and protein production.
-
Full-text index only
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
PMID 41593194 · PMC13004670 · Nature medicine · 2026 · 8 claims · 5 setups
PD-1 blockade induces tumor-specific IgG1+ plasma cell responses that complement cellular immunity and contribute to clinical benefit